Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dolan

Showing results (51-60 of 224) with videos related to

Pageof 23
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996
Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferaseS K Roy, R C Moschel, M E Dolan
Gynecologic Oncology|December 1, 1975
Cytology, colposcopy, and directed biopsy: what are the limitations?T E Dolan, J Boyce, Y Rosen, et al.
Biochemical Pharmacology|November 29, 1994
Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivoU K Marathi, M E Dolan, L C Erickson
Cancer Research|August 15, 1994
Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicityU K Marathi, M E Dolan, L C Erickson
Military Medicine|June 26, 1998
Ventilator-related Acinetobacter outbreak in an intensive care unitT R Cox, W E Roland, M E Dolan
Stem Cells (Dayton, Ohio)|November 20, 2001
High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cellsM H Wu, S L Smith, M E Dolan
Progress in Nucleic Acid Research and Molecular Biology|January 1, 1995
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferaseA E Pegg, M E Dolan, R C Moschel
Cancer Research|March 1, 1992
Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formationR B Mitchell, R C Moschel, M E Dolan
The Journal of Otolaryngology|April 1, 1991
Acoustic neuroma presenting as a middle ear massP J Stoney, J Rutka, E Dolan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agentsM E Dolan, R C Moschel, A E Pegg
Pageof 23

Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996
Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferaseS K Roy, R C Moschel, M E Dolan
Gynecologic Oncology|December 1, 1975
Cytology, colposcopy, and directed biopsy: what are the limitations?T E Dolan, J Boyce, Y Rosen, et al.
Biochemical Pharmacology|November 29, 1994
Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivoU K Marathi, M E Dolan, L C Erickson
Cancer Research|August 15, 1994
Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicityU K Marathi, M E Dolan, L C Erickson
Military Medicine|June 26, 1998
Ventilator-related Acinetobacter outbreak in an intensive care unitT R Cox, W E Roland, M E Dolan
Stem Cells (Dayton, Ohio)|November 20, 2001
High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cellsM H Wu, S L Smith, M E Dolan
Progress in Nucleic Acid Research and Molecular Biology|January 1, 1995
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferaseA E Pegg, M E Dolan, R C Moschel
Cancer Research|March 1, 1992
Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formationR B Mitchell, R C Moschel, M E Dolan
The Journal of Otolaryngology|April 1, 1991
Acoustic neuroma presenting as a middle ear massP J Stoney, J Rutka, E Dolan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agentsM E Dolan, R C Moschel, A E Pegg
Pageof 23